Metal-organic frameworks (MOFs) are promising platforms for the synthesis of nanoparticles for diverse medical applications. Their fundamental design principles allow for significant control of the framework architecture and pore chemistry, enabling directed functionalization for nanomedical applications. However, before applying novel nanomaterials to patients, it is imperative to understand their potential health risks. In this study, the nanosafety of different MOF nanoparticles is analyzed comprehensively for diverse medical applications. The authors first evaluate the effects of MOFs on human endothelial and mouse lung cells, which constitute a first line of defense upon systemic blood-mediated and local lung-specific applications of nanoparticles. Second, we validated these MOFs for multifunctional surface coatings of dental implants using human gingiva fibroblasts. Moreover, biocompatibility of MOFs is assessed for surface coating of nerve guidance tubes using human Schwann cells and rat dorsal root ganglion cultures. The main finding of this study is that the nanosafety and principal suitability of our MOF nanoparticles as novel agents for drug delivery and implant coatings strongly varies with the effector cell type. We conclude that it is therefore necessary to carefully evaluate the nanosafety of MOF nanomaterials with respect to their particular medical application and their interacting primary cell types, respectively.
Introduction
Nanosized materials have been used for various biomedical applications to improve human disease diagnosis and treatment. These nanomedicines can offer various advantages in of application for MOFs, ranging from diagnosis and sensing to therapeutic drug delivery and multifunctional surface modification of medical implants (Figure 1) .
The same nanomaterials that have been developed for improving diagnosis and therapy, however, may impose health risks to the patient very similar to those known from occupational or environmental particle exposures. [26] [27] [28] As such, the application of any novel nanomaterial in the medical context calls for thorough and comprehensive analysis of its cellular biocompatibility and thus nanosafety. In particular, NPs are required to only minimally interfere with the function of their primary effector cells, which are defined as those cells that directly interact with NPs when these are introduced into the biological system. Most surprisingly, so far MOF NPs have not been comprehensively analyzed for their adverse effects on primary effector cells, but have mainly been studied for their in vitro toxicity in cancer cells. [10, 29] Here, we intend to fill this gap by determining and discussing the adverse effects of different MOF NPs for various medical applications ranging from drug delivery to surface coating of medical implants. We here investigated different types of MOF NPs that have distinct properties. All NPs tested in this study have a spherical morphology in common because studies suggested that this particular shape causes least cytotoxicity. [21] For chemical composition and surface charge diversity we choose a Zr-fumarate (Zr-fum) MOF, a Fe-trimesate (MIL-100, MIL standing for Material of Institute Lavoisier), and a Cr-terephthalic MOF (MIL-101). The Zr-fumarate MOF [30] features microporosity of 5-8 Å whereas MIL-100(Fe) [31] and MIL-101(Cr) [32] exhibit mesoporosity of 25-28 and 3034 Å, respectively. A characteristic feature of the Zr-fumarate MOF is the fumaric acid linker which is an intermediate in the citric acid cycle and hence a biocompatible molecule. Such microporous MOFs as well as the MIL-100(Fe) and MIL-101(Cr) are particularly well suited for external surface functionalization and transport of large biomolecules such as RNA. [18] The mesoporosity of MIL-100(Fe) and MIL-101(Cr) allows for the storage of drug molecules inside the nanoparticles and at the same time features chemical stability. [32, 33] These particles are particularly promising for drug delivery applications. [34] For systemic delivery of any type of functionalized MOF NP by intravenous injections, the endothelium is the first site of particle contact and uptake. It tightly seals the vessel wall to the surrounding tissue and maintains blood barrier integrity as well as controls local inflammatory responses. In contrast to blood cells, which also encounter nanoparticles upon systemic delivery, endothelial cells are less easily replenished upon damage. Any cytotoxic effects by NPs will thus have a profound effect on endothelial barrier function. We thus assayed survival, apoptotic cell death, and inflammatory activation of human primary endothelial cells in response to treatment with our MOF-NPs.
An additional way of NP delivery is their inhalation via the lung. In fact, inhalation of NPs is a natural route of entry to the body as evidenced by the sometimes detrimental uptake of environmental nanoparticles. [35] Hence, the lung is a unique organ particularly suitable for local drug delivery via inhalation. Its large surface area, thin epithelium layer, and rich blood supply allow for rapid uptake of inhalatively applied nanoparticles. [3] To assess the biocompatibility of our MOF NPs for inhalative applications into the lung, we investigated the cellular responses of murine alveolar epithelial cells that constitute the main cell type of the air/blood barrier. In addition, we analyzed activation of the main immune cell type of the lung, the alveolar macrophages. These cells are of key importance for clearing particles and toxins from the lung and thus control the initial inflammatory response of the lung to foreign material.
Moreover, we envision the use of MOF NPs for coatings as a promising field of application (Figure 1 ), as already proposed in the literature. [36, 37] Medical implants are mainly artificial structures that are widely applied in the clinic to facilitate cellular regeneration of substitute body functions. Activatable coatings on medical implants allow for the control of adverse inflammatory reactions after implantation and progressive implant and tissue destruction. [38] [39] [40] [41] To study the general applicability of MOF NPs in this field, we assayed the cytotoxicity of chemically stable MIL-100(Fe), MIL-101(Cr), and Zr-fum MOF NPs of different sizes on primary gingiva fibroblasts as effector cells for dental implants.
A different type of medical implants is represented by nerve guidance tubes that are used to bridge transected peripheral nerves in reconstruction surgeries (Figure 1 ). Currently autologous nerve tissue is used for transplantation to the site of injury. Entubulation strategies with synthetic hollow nerve guidance conduits represent a promising alternative to autologous nerve tissue transplantation to facilitate peripheral nerve regeneration. [42] Functionalization of biosynthetic nerve guidance tubes may be applied in order to deliver regeneration promoting (3 of 11) 1600818 molecules facilitating attraction of Schwann cells. [43] [44] [45] [46] To address these issues, we investigated our MOF NPs regarding their biocompatibility with primary adult human Schwann cell cultures as well as in organotypic cultures of rat dorsal root ganglia that contain sensory neurons.
All in all, the aim of our study was to comprehensively investigate the nanosafety and hence the general applicability of different MOF NPs for distinct fields of medical applications. For this purpose, the different experimental setups were designed to be as close as possible to the later applications by the use of the primary effector cells, i.e., endothelial, lung, gingiva, and nerve cells, of the respective application field.
Results

Synthesis and Characterization of the MOF Nanoparticles
Validation of biocompatibility was performed with different MOFs that provide promising properties for the use as drug nanocarrier as well as for the multifunctional surface coating of implants. The structure and phase purity of the nanoparticles were characterized by powder X-ray diffraction Figures S3, S7 , and S11, Supporting Information) are in good agreement with reported data. [30, 34] The hydrodynamic diameters of the different nanoparticles determined with dynamic light scattering (DLS) range from about 40 to 250 nm ( Figures S4, S8 , and S12 and Table S1 , Supporting Information). The formation of a supported lipid bilayer around the MIL-100(Fe) and MIL-101(Cr) nanoparticles, i.e., 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), enhances their biocompatibility and prevents incorporated cargo from premature release. [34] The smaller hydrodynamic diameter of the MIL-100(Fe)@DOPC in comparison with pure MIL-100(Fe) nanoparticles can be explained by the agglomeration behavior of the latter. This tendency to form agglomerates is prevented by a lipid bilayer. [34] Zeta potential measurements were used to determine the effective charge of the nanoparticles and range from 3 to −43 mV for the nanoparticles investigated (Table S1 , Supporting Information).
Evaluation of Nanosafety of MOF Nanoparticles Designed for Drug Delivery
For the delivery of mesoporous NPs by either intravenous or inhalative routes, the endothelial and alveolar cell barriers need to be overcome without causing cell damage and activation of inappropriate immune responses. We thus examined the cellular response toward MIL-101(Cr) and MIL-100(Fe) MOF NPs with and without supported lipid bilayers in endothelial cells, alveolar epithelial cells, and alveolar macrophages and compared it to the response toward nonlipid-coated control particles.
Human endothelial cells, namely primary human umbilical cord vein cells (HUVEC) and human microvascular endothelial cells (HMEC), were cultured to confluency, exposed for up to 72 h to DOPC-coated iron or chromium MOFs at a dose range of 25-200 µg mL −1 and assayed for cytotoxic and inflammatory responses compared to nontreated and noncoated particle controls. Staining of HMECs for the cytoskeletal actin protein did not reveal any stress-related rearrangement of actin fibers in response to 24 h of exposure to MOF nanoparticles (Figure 2A and Figure S13 , Supporting Information). We further analyzed for early signs of apoptotic cell death using fluorescence activated cell sorting (FACS)-based analysis of the DNA content. This technique allows for separation of cells according to their DNA content in the different phases of the cell cycle with dividing S and G2 phase cells containing the doubled amount of DNA compared to cells in the resting G1 phase ( Figure S14 , Supporting Information). Apoptotic cells contain fragmented DNA and can thus be quantified by counting the cells in a sub-G1 peak. [47] MIL-101(Cr)@DOPC and also uncoated MIL-101(Cr) did not induce any signs of apoptotic cell death for the full dose range when applied to HMECs for 72 h. MIL-100(Fe)@DOPC treated HMECs had an increased sub-G1 peak only at the highest particle dose of 200 µg mL −1 , revealing significant induction of apoptosis with high doses of lipid-coated MIL-100(Fe) particles ( Figure 2B ). This was also observed for the noncoated control particles and indicated that Fe-containing MOFs induce apoptotic cell death in endothelial cells at higher doses. Endothelial cells are easily activated upon cell damage by noxious stimuli and particles to express proinflammatory surface receptors such as the intercellular adhesion molecule (ICAM). These surface molecules serve as binding sites to capture patrolling immune cells in the blood for activation of local inflammatory responses. Expression of ICAM1, however, was not affected in HUVECs by any of the particles tested as shown by FACS-based quantification of ICAM1 expression after 24 h of particle treatment in Figure 2C . We here used tumor necrosis factor α (TNFα) as a positive control to obtain maximal induction of ICAM surface expression upon inflammatory signaling via TNFα. [48] In a next step, we studied the cytotoxic effects of the MOF nanoparticles for lung cells, namely murine alveolar epithelial cells (MLE12) and mouse alveolar macrophages (MH-S). Viability of the cells was quantified after 24 h of particle exposure using the MTT assay which uses conversion of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) into (E,Z)-5-(4,5-dimethylthiazol-2-yl)-1,3-diphenylformazan (Formazan) by metabolically active and thus viable cells. In addition, we measured the amount of lactate dehydrogenase (LDH) in the medium which is released by necrotic cells with disrupted plasma membranes. Viability of MLE12 cells was affected by exposure to higher doses of MIL-101(Cr)@DOPC (200 µg mL −1 ), which corresponded to an increased release of LDH ( Figure 3A ). Exposure to MIL-100(Fe)@DOPC particles resulted in an even stronger inhibitory effect on metabolic activity and was cytotoxic from doses of 100 µg mL −1 on ( Figure 3A) . These cytotoxic effects were even stronger with uncoated Figure 3A) showing that lipid functionalization improves biocompatibility of both the MIL-100(Fe) and MIL-101(Cr) nanoparticles in lung epithelial cells, respectively. Biocompatibility of Fe-containing MOFs was, however, strikingly different from Cr-MOFs in the alveolar macrophage cell line MH-S. Both DOPC coated and uncoated Fe-MOFs showed drastically reduced cell viability in MTT and LDH assays ( Figure 3B ), while Cr-MOFs were well tolerated and only induced cell death at the highest dose of 200 µg mL −1 ( Figure 3B ). To investigate the inflammatory response of these particles in the alveolar macrophages, we determined RNA expression levels of wellknown proinflammatory mediators such as the cytokine interleukin 6 (IL6), TNFα, and of the enzyme nitrite oxide synthase 2 (Nos2) which generates high levels of nitric oxide as part of the phagocytotic response of macrophages toward microorganisms, toxins, and particles. [49] In addition, we measured expression of heme oxygenase 1 (HO1) and metallothionein 2 (MT2) that are activated as part of the cellular stress response to metals such as iron. [50, 51] As a positive control for efficient induction of these genes, we stimulated MH-S cells with the lipopolysaccharide (LPS), a bacterial wall component that is a strong and well-known trigger for inflammatory gene expression ( Figure 3C ). [52] While LPS strongly induced expression of IL6, TNFα, and Nos2, we did not observe any obvious inflammatory gene activation for the tested MOF nanoparticles ( Figure 3C ). In contrast, Fe-containing MOFs induced distinct and dose-dependent upregulation of HO1 and MT2 suggesting pronounced activation of an antiiron-stress response in alveolar macrophages. Cr-containing MOFs, however, were inert ( Figure 3C ).
Taken together, these data indicate that both Fe and Cr-containing MOFs are well tolerated by endothelial cells whereas the MIL-100(Fe)@DOPC NPs caused some apoptotic cell death from a minimum dose of 100 µg mL −1 onward. In contrast, alveolar epithelial cells are generally more sensitive and tolerate only lipid-coated Fe and Cr-containing MOFs at lower doses of up to 50-100 µg mL −1 , respectively. Alveolar macrophages appear to be particularly sensitive to iron-containing MOF particles, which cause pronounced induction of a cellular stress response. In contrast, Cr-containing MOFs are well tolerated by these immune cells.
Evaluation of Nanosafety of MOF Nanoparticles Designed for Implant Coatings
While NPs have been primarily used as mobile nanocarriers in medical applications, they can also be used to modify solid surfaces such as dental implants or cellular guidance structures. [44, 46, 53] In order to evaluate the influence of particle size, chemical composition, and surface charge, we examined Zr-fum MOF, MIL-100(Fe), and MIL-101(Cr) MOF NPs (Table S1 , Supporting Information). In proof-of-concept experiments, we investigated the biological effect of the different MOF NPs on gingival fibroblasts, adult human Schwann cells as well as rat neonatal organotypic dorsal root ganglion (DRG) cultures as effector cell systems for dental implants and nerve guidance tubes, respectively.
We first tested primary human gingival fibroblasts for their cytotoxic response toward the above-mentioned MOF NPs (Figure 4) .
Remarkably, all of the tested MOF NPs showed only minor signs of cytotoxicity on gingiva fibroblasts: while Zr-fum MOFs were well tolerated even at higher doses as revealed by LDH release assays and Zr-fum MOF large NP only responded with some decrease in metabolic activity, MIL-100(Fe) or MIL-101(Cr) particles showed some significant increase in LDH release with doses of 50 mg mL −1 and higher but no significant decrease in metabolic activity indicating that they are well tolerated ( Figure 4 ). Scanning electron microscopy (SEM) analysis did not reveal any obvious morphological signs of cell death after incubation with Zr-fum MOF NPs ( Figures S15(A-D) , Supporting Information).
With regard to NP coating of nerve guidance channels, we used human primary adult Schwann cells as they are the . Biocompatibility of MOFs with human primary gingival fibroblasts. Metabolic activity (MTT test) and toxicity (LDH-assay) after 24 h of exposure of gingival fibroblasts to Zr-fum MOF small , Zr-fum MOF large , MIL-100(Fe), or MIL-101(Cr) particles, respectively. Untreated cells were set to 100% metabolic activity for the MTT test and to 0% toxicity for the LDH assay. Values given are mean of three independent experiments ± SEM. * indicates a significant change compared to the respective controls (p < 0.05).
(7 of 11) 1600818 leading supporting cells for peripheral nerve regeneration. [54] Moreover, Schwann cells are in direct contact with the NP coating on the inner surface of nerve guidance channels (Figure 1 ). We first analyzed the morphology and metabolic activity of adult human Schwann cells cultures after 72 h in response to different doses of the MOF NPs (Figure 5A,B) . We detected a pronounced formation of cell clusters when cultures were treated with doses of 200 µg mL −1 of the different MOF NPs, except for Zr-fum MOF large ( Figure 5A ). In contrast, lower doses of MOF NPs ranging from 12.5 to 50 µg mL −1 did not induce any obvious morphological alterations in the growth behavior of adult human Schwann cells ( Figure 5A ). This corresponded well to the preserved metabolic activity in the presence of most of the MOF NPs at doses up to 50 µg mL −1 ( Figure 5B ). For the adult human Schwann cells, we used the Water Soluble Tetrazolium (WST) assay to determine metabolic activities. This test is based on the same principle as the MTT test, but easier to use in difficult cell culture systems due to water-solubility and storage conditions. MIL-100(Fe) as well as MIL-101(Cr) nanoparticles reduced metabolic activity of adult human Schwann cell at doses of 50 µg mL −1 . This did not, however, reach statistical significance and is probably not be related to cell deathas indicated by maintenance of cellular morphology-but may reflect an altered metabolic state of the cells in response to treatment. Metabolic activity was reduced up to ≈50% of untreated cultures at the highest dose of 200 µg mL −1 . In presence of Zr-fum MOF NPs, the metabolic activity of the cells was almost not affected in a dose range up to 50 µg mL −1 while the highest concentration of 200 µg mL −1 of Zr-fum MOF large did significantly reduce metabolic activity up to ≈65% of untreated controls ( Figure 5B ). In contrast, Zr-fum MOF small did not affect the metabolic activity of adult human Schwann cells in culture at any concentration tested. These data indicate that MOF NPs are generally well tolerated by human adult Schwann cells irrespective of the organic components, metal ion content, and size at low doses.
In addition to Schwann cells, we monitored the biological response of sensory neurons to the MOF NPs using rat neonatal organotypic DRG cultures. The particular feature of these DRGs cultures is that they contain sensory neurons that extend their axons (neurites) into the peripheral space thus mimicking axonal outgrowth to the periphery. Therefore, these cultures provide a unique opportunity to study the response of the main effector cell type for nerve guidance tubes, i.e., neurite outgrowth behavior of sensory neuronal cells, to novel types of nanomaterial. [44, 55] In this assay, the neurite outgrowth from neonatal rat DRG cultures is quantified by counting the numbers of neurites crossing a circle drawn at 600 µm distance from the center of each DRG ( Figure 5C ). Figure 5C shows representative photoimages of untreated control DRG and of cultures that have reduced neurite outgrowth upon treatment with the different MOF-NPs added in two concentrations.
As an example for a treatment that showed a dose-dependent effect on neurite outgrowth, representative pictures from the MIL-100(Fe) treated cultures are shown: surprisingly, the low concentration of 50 µg mL −1 MIL-100(Fe) significantly reduced sensory neurite outgrowth while the doubled concentration rescued it to control levels. For Zr-fum MOF small and MOF large , we did not observe any loss in neurite outgrowth capacity at both doses tested ( Figure 5C ).
In conclusion, these data demonstrate the principal feasibility of using MIL-100 (Fe) and MIL-101(Cr) as well as Zr-fum MOF NPs for coating of dental implants as they were well tolerated by human gingiva fibroblast. For coating of nerve guidance tubes, however, Zr-fum MOF large NPs appear to be the most suitable choice as they were best tolerated in both adult human Schwann cells and rat dorsal root ganglia up to doses of 50 µg mL −1 , respectively.
Discussion
In this study, we comprehensively analyzed the nanosafety of different MOF NPs with regard to distinct biomedical applications, ranging from systemic blood and local lung-specific drug delivery to coatings of dental implants and nerve guidance tubes ( Table 1) .
During systemic nanoparticle-mediated drug delivery via the blood, nanomaterials get in contact with the endothelium of the vessels. We show that primary human endothelial cells are not affected by the tested MOF NPs, i.e., MIL-100(Fe) and MIL-101(Cr) and their DOPC-coated derivatives up to high doses of 200 µg mL −1 toward with regard to apoptotic cell death or inflammatory responses. Similar results have been shown previously for the hepatocarcinoma cell line Hep3B. [29] This identifies these MOF NPs to be potentially suitable nanomaterials for systemic delivery via the blood. Although pharmacokinetics, such as transendothelial migration, absorption, biodistribution, and elimination, of the MOF NPs needs to be investigated in further studies, the fact that these NPs do not destroy the endothelium forms a mandatory prerequisite for potential intravenous (i.v.) application in the future.
Our data on the lung-specific applications of MOFs demonstrate that differences in the composition of the MOF NPs reflect directly on the bioresponse of the cells. In general, both lung epithelial and alveolar macrophage cell lines were clearly more sensitive to the lipid-coated and noncoated MIL-100(Fe) and MIL-101(Cr) NPs compared to the primary human endothelial cells. This might be related to the differential cell culture conditions, as endothelial cells were cultured as a confluent and tight cell monolayer, while the lung cells were grown at subconfluent conditions. However, subconfluent dental fibroblasts were not sensitive to noncoated MIL-100(Fe) and MIL-101(Cr) nanoparticles. Thus, these differential sensitivities most probably reflect the intrinsic differences between the different cell types as also indicated by the differential sensitivity of lung epithelial and lung immune cells to the MOF NPs. Alveolar macrophages showed a striking sensitivity toward iron-containing MOF NPs. MIL-100(Fe)-and MIL-100(Fe)@DOPC-induced toxicity was accompanied by early upregulation of antiiron stressresponse genes. Of note, the iron-containing MOF NPs did not induce upregulation of early inflammatory marker genes such as IL-6, TNFα, and Nos2 which are well known mediators of an acute inflammatory response in the lung to foreign material. [56] This is well in line with the previously observed differential response of alveolar macrophages to diverse nanomaterials. [56] Alveolar epithelial cells tolerated these particles well up to doses of 100 µg mL −1 . In contrast, Cr-containing MOF NPs were well tolerated by both alveolar epithelial cells and alveolar macrophages at doses up to 100 µg mL −1 . We tentatively attribute this different behavior to the high chemical stability of A second important observation from our study on the pulmonary effector cells is that lipid-coated MOF NPs were better tolerated by alveolar epithelial cells than their noncoated counterparts. This may be due to improved cellular uptake as previously shown by some of us. [34] The lipid layer might also act as a stealth coating, thus preventing certain cellular response mechanisms from being activated. In conclusion, lung epithelial and immune cells are less sensitive to Crbased MOF NPs and induce no adverse cytotoxic effects at the low and middle dose range. These particles can therefore be envisioned as biocompatible nanocarriers for inhalative lungspecific drug delivery, whereas the Fe-based MOF NPs do not seem to be suitable for pulmonary applications. Nanoparticlemediated drug delivery into the lung via inhalation represents a novel concept for treatment of lung diseases. [57, 58] It is hampered, however, by the fact that the applied nanocarriers have detrimental side effects for the lung which may either result from acute inflammation and cytotoxicity or upon their accumulation in lung tissue over time causing chronic lung inflammation as shown previously. [59] The here studied MOFs represent a novel type of biodegradable nanomaterial which may possibly overcome these limitations. Nanosafety of MOF NPs for surface coating of dental implants was tested in primary human gingiva fibroblasts, which are the effector cells that are in direct contact with nanoparticle-coated grafts. Notably, these cells showed no obvious toxic response toward the tested MOF NPs, i.e., MIL-100(Fe) and MIL-101(Cr) and Zr-fum MOF small and MOF large . In both assays applied, i.e., measurement of metabolic activity and release of LDH, gingival fibroblasts did not reveal a significant toxic response. Moreover, maintenance of the fibroblastoid morphology of the cells indicated good biocompatibility. The lack of toxicity of the MOF NPs in a wide dose range supports a possible application for coatings of dental implants. Regarding a future application of MOF NPs as coating and nanocarrier for nerve guidance tubes, our data demonstrate the biocompatibility of the MIL-100(Fe) and MIL-101(Cr) as well as Zr-fum MOF small and MOF large NPs with adult Schwann cells in the low dose range. MOF NPs were also generally well tolerated by cultures of dorsal root ganglia and did not notably interfere with the outgrowth of neuronal axons with the prominent exception of Fe-containing MOFs. In particular the low cytotoxic response of adult Schwann cells as well as the inert behavior of sensory neurons toward Zr-fum MOF large particles makes those MOF NPs a promising formulation for surface coating of nerve guidance tubes as suggested previously for polysialic acid and its mimetics. [60] [61] [62] Recently we were able to demonstrate that iron oxide nanoparticles potentially provide a biocompatible tool to delivery of neurotrophic factors in peripheral nerve reconstruction approaches. [44, 63] Our data on the MOF NPs provide now evidence for their potential as delivery system of regeneration promoting peptides within nerve guidance channels.
In conclusion, our data on the biocompatibility of the MIL-100(Fe) and MIL-101(Cr) and the Zr-fum MOF NPs are well in line with published studies on cellular uptake. [12, 13, 18, 19, 25, 34] The most important finding of our comprehensive validation is that there are striking differences in the bioresponse of the diverse effector cell types to the distinct MOF-NPs (Table 1 ). For the MIL-100(Fe) and MIL-101(Cr) particles, differential responsiveness appears to be directly related to intrinsic differences of the cell types as colloidal stability of these MOFs has been shown to be preserved in different cell culture media for at least 24 h. [29] Lipid-coated MIL-101(Cr) MOF NPs can be envisioned so far as safe nanoagents for intravenous systemic drug delivery. We have previously shown that the lipid-coated MIL-100(Fe) and MIL-101(Cr) MOF NPs are taken up and well tolerated by the T24 bladder carcinoma cell line suggesting that lipidcoated MOF NPs might be feasible nanocarriers for delivery of cytotoxic drugs to tumor cells. [34] In addition, MIL-100(Fe) and MIL-101(Cr) together with Zr-fum MOF NPs might be suitable nanoparticles for surface coating of dental grafts. Zr-fum MOF large NPs appear to be promising nanomaterial for inner surface modification of nerve guidance tubes. Of note, the lung is particularly sensitive to any nanomaterial but lipid-coated MIL-101(Cr) MOF NPs might be appropriate nanoagents for inhalative drug delivery at a low to middle dose ranges. The particular sensitivity of the lung to nanomaterial is well known and constitutes the basis for the hazardous effects of inhalatively taken up environmental NPs. [28] These results unambiguously demonstrate the requirement for thorough testing of nanomaterials for their respective nanosafety in specific biomedical applications as suggested recently. [26, 58] 
Conclusion
MOF chemistry offers a unique platform to create functional NPs for different biomedical applications with improved biocompatibility. However, NPs have been shown to bear potential risks for human health. Therefore, we validated various MOF NPs for specific medical fields of application. To the best of our knowledge, this is the first time that such NPs have been systematically evaluated for their biocompatibility with their primary effector cells. We demonstrate that the tested MOF NPs show differential toxicity and bioresponse in different effector cells tested. Thus, this work defines a novel strategy that, in addition to highlighting the potential important risks of using MOF NPs for specific medical purposes, also demonstrates their differential suitability for applications in drug delivery and for implant coating. Importantly, for the first time we envision the use of MOF NP coatings for dental implants or cellular guidance tubes and show their nanosafety regarding the respective effector cells, such as gingiva fibroblasts and peripheral nerve cells.
Our results thus clearly demonstrate the requirement for thorough testing of nanomaterials regarding their nanosafety in specific biomedical applications as suggested recently and illustrate the impact of the molecular interface of the MOF NPs for their respective use for systemic drug delivery and surface modification of implants. [26, 56] 
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